Most guys know something's off — they just can't name it. In this episode, Rick and Greg break down what to actually do about low testosterone: the lifestyle foundation that has to come first, the supplements worth considering (including why boron is getting more attention than it used to), and the three medication-based options your provider might discuss — SERMs, HCG, and full testosterone replacement therapy.

They also walk through the difference between total and free testosterone, why you can have a "normal" number and still feel terrible, and why medication without the foundation is a losing game.

If you've been dragging, or you know someone who has, this is the episode. Ladies, this one's for your husbands too.

Topics covered: sleep, resistance training, HIIT, nutrition, vitamin D, zinc, boron, sex hormone binding globulin, clomiphene, enclomiphene, HCG/Pregnyl, testosterone replacement therapy (injections and creams), LH/FSH signaling, cortisol and stress, and how to structure the conversation with your medical provider.

For informational and educational purposes only. Consult your licensed medical provider before beginning any hormone therapy, supplement, medication, or lifestyle program.

In this episode, Rick and Greg turn their focus to men's health — specifically the quiet, decades-long decline in testosterone levels and why so many men are being told they're "fine" when they're anything but.

They walk through the classic patient story that Greg hears constantly in the clinic: a man in his forties or fifties, gaining weight in the midsection, losing muscle despite working out, mentally foggy, low energy, increasingly irritable — and sent home with a normal lab result and a shrug. Rick and Greg explain why total testosterone alone is an incomplete picture, how the standard advice of "just be more active" can actually work against men with low T, and why this is a cyclical, compounding problem that gets harder to escape the longer it goes unaddressed.

They also get into the broader science: how testosterone connects to visceral fat, insulin sensitivity, metabolic function, and overall quality of life — and why framing it as just a "sex hormone" or a bodybuilder drug has led to years of under-diagnosis and dismissal.

This is part one of a multi-episode series on hormones. Next episode: symptoms to watch for, what age to start checking, and the full range of treatment options beyond injectable testosterone.

Rick and Greg are medical providers, but not your medical provider. Consult your personal provider before starting any medication, hormone therapy, or health program.

Rick and Greg take a detour from their upcoming hormones series to address a topic that comes up constantly in the clinic: the stigma surrounding GLP-1 medications for weight loss.

If you've ever heard — or thought — "they took the easy way out," this episode is for you. They walk through the most common myths about medication-assisted weight loss, explain why these beliefs are medically unfounded, and explore the real-world consequences of that stigma: people delaying or avoiding treatment for a legitimate chronic disease.

The guys also reference a recent study in which participants judged a fictional GLP-1 user more negatively than someone who lost no weight at all — a striking finding that puts the cultural bias on full display.

Topics covered: the "cheating" narrative, social circle influence, celebrity distortion, the gender gap in weight loss criticism, and why supporting someone's health journey — whatever form it takes — is always the right call.

Rick and Greg are medical providers, but not your medical provider. Consult your personal provider before beginning any weight loss program, medication, or supplement.

In this episode, Rick and Greg discuss a groundbreaking 2026 policy statement from leading obesity organizations that redefines how obesity should be treated in modern medicine.

The key takeaway: Obesity is a chronic, biologically driven disease—and it’s being significantly underdiagnosed and undertreated.

The new guidelines emphasize:

• Earlier and more aggressive intervention
• Combining lifestyle changes with medication, not delaying treatment
• Strong evidence supporting the safety and effectiveness of long-term obesity medications
• A shift away from focusing solely on weight toward broader health outcomes like cardiovascular risk, diabetes prevention, and overall quality of life

Rick and Greg also highlight a critical reality: stopping treatment often leads to weight regain, reinforcing the need to view obesity like other chronic diseases that require ongoing management.

This episode underscores a major shift in healthcare—from treating complications to addressing obesity at its root, earlier and more effectively.

In this episode of Healthier Ever After, Rick and Greg explore the often-overlooked impact of obesity stigma—and why it may be one of the biggest barriers to better health.

Drawing from recent policy statements and research, they unpack how weight bias shows up in healthcare, media, workplaces, and everyday life, and how it contributes to depression, anxiety, social withdrawal, and even avoidance of medical care .

The conversation highlights a critical shift in thinking:
➡️ Obesity is not a personal failure
➡️ It is a complex, chronic disease influenced by biology, genetics, and environment

Rick and Greg also discuss:

• How stigma leads to worse health outcomes—not better ones
• Why many patients feel dismissed with “just lose weight”
• The importance of team-based, solution-focused care
• How to balance honesty about health risks with respect and compassion

This is a thoughtful, honest conversation about a sensitive topic—aimed at helping patients feel seen, supported, and empowered.

In this episode, Rick and Greg discuss a groundbreaking 2026 policy statement from leading obesity organizations that redefines how obesity should be treated in modern medicine.

The key takeaway: Obesity is a chronic, biologically driven disease—and it’s being significantly underdiagnosed and undertreated.

The new guidelines emphasize:

• Earlier and more aggressive intervention
• Combining lifestyle changes with medication, not delaying treatment
• Strong evidence supporting the safety and effectiveness of long-term obesity medications
• A shift away from focusing solely on weight toward broader health outcomes like cardiovascular risk, diabetes prevention, and overall quality of life

Rick and Greg also highlight a critical reality: stopping treatment often leads to weight regain, reinforcing the need to view obesity like other chronic diseases that require ongoing management.

This episode underscores a major shift in healthcare—from treating complications to addressing obesity at its root, earlier and more effectively.

In this episode, Rick and Greg discuss why protecting muscle mass during weight loss is essential for real, lasting health. They explain that while GLP-1 medications can be powerful tools for weight loss, the real key to staying healthy during that process is making sure you are losing fat, not valuable lean mass.

They explore how muscle functions as more than a cosmetic feature — it is a major driver of metabolism, glucose use, strength, resilience, and healthy aging. The conversation also covers why exercise, especially resistance training, is critical, how protein intake supports muscle preservation, and why body composition matters more than the scale alone.

Rick and Greg emphasize a simple message: GLP-1s are a tool, not the whole plan. If you want healthier weight loss, you need to use your muscles, feed your muscles, and build habits you can sustain long term. They also spotlight whey protein as their supplement of the week and mention their supplement line available at getweightwise.com.

This episode is for educational and informational purposes only. Be sure to speak with your medical provider before beginning any weight loss, exercise, or supplement program.

In this episode, Rick and Greg explore effective weight loss options outside of GLP-1 medications, offering a practical and medically grounded look at alternatives for patients who cannot tolerate or access these newer therapies.

They begin with a discussion of weight loss physiology, emphasizing the roles of hormones, appetite regulation, and metabolic signaling—highlighting why willpower alone is often insufficient for long-term success.

The episode then reviews several evidence-based options, including:

• Phentermine, a long-standing and cost-effective stimulant that reduces appetite and increases energy
• Topiramate, a medication that targets cravings and reward pathways in the brain
• Combination therapy (phentermine + topiramate) for enhanced outcomes
• Orlistat, which reduces fat absorption but carries notable gastrointestinal side effects

They also discuss off-label use of metformin, particularly for improving insulin sensitivity and stabilizing metabolic function, as well as berberine, a supplement with similar mechanisms.

As part of a comprehensive approach to weight loss, Rick and Greg also highlight the role of targeted nutritional supplementation. Their supplement line, available at GetWeightWise.com, is designed to support individuals navigating medically guided weight loss—helping address common challenges such as energy levels, metabolic support, and medication-related side effects.

A key focus of the episode is the importance of working with a medical provider, as studies and clinical experience consistently show improved outcomes with supervision, accountability, and individualized treatment plans.

The episode concludes with insights into emerging evidence that personalized dosing strategies—especially with weight loss medications—can significantly improve results compared to standardized protocols.

Disclaimer:

This podcast is for informational and educational purposes only and does not constitute medical advice. Listeners should consult their healthcare provider before making any medical decisions.